Prostate cancer with nodular bladder invasion (stage T4N1) cured by low-dose-rate brachytherapy with seminal vesicle implantation in combination with external beam radiotherapy of...

por Okamoto, Keisei
Publicado 2021

Ten‐step method of high‐dose LDR (125)I brachytherapy for intermediate‐risk prostate cancer

por Okamoto, Keisei
Publicado 2021

Very high-risk locally advanced prostate ductal adenocarcinoma cured using low-dose-rate brachytherapy, with seminal vesicle implantation in combination with external beam radiothe...

por Okamoto, Keisei
Publicado 2022

High biologically effective dose radiation therapy using brachytherapy in combination with external beam radiotherapy for high-risk prostate cancer

por Okamoto, Keisei, Wada, Akinori, Kohno, Naoaki
Publicado 2017

Clinical outcomes of low-dose-rate brachytherapy based radiotherapy for intermediate risk prostate cancer

por Okamoto, Keisei, Okuyama, Kahori, Kohno, Naoaki, Tsugawa, Takuya
Publicado 2020

Low Incidence of Point Mutations in H‐, K‐ and N‐ras Oncogenes and p53 Tumor Suppressor Gene in Renal Cell Carcinoma and Peritoneal Mesothelioma of Wistar Rats Induced by Ferric Ni...

por Nishiyama, Yasuyuki, Suwa, Hirofumi, Okamoto, Keisei, Fukumoto, Manabu, Hiai, Hiroshi, Toyokuni, Shinya
Publicado 1995

Pharmacokinetic/Pharmacodynamic Analysis of a Hemodialyzed Patient Treated with 25 mg of Sunitinib

por Noda, Satoshi, Kageyama, Susumu, Tsuru, Teruhiko, Kubota, Shigehisa, Yoshida, Tetsuya, Okamoto, Keisei, Okada, Yusaku, Morita, Shin-ya, Terada, Tomohiro
Publicado 2012